Debika Bhattacharya

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: A novel approach
    Debika Bhattacharya
    Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States UCLA Center for AIDS Research and Education, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States Electronic address
    J Virol Methods 190:34-40. 2013
  2. pmc Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance
    D Bhattacharya
    Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J STD AIDS 19:780-1. 2008
  3. pmc Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis
    Debika Bhattacharya
    University of California, Los Angeles, CA, USA
    J Acquir Immune Defic Syndr 55:170-5. 2010
  4. pmc Review of hepatitis B therapeutics
    Debika Bhattacharya
    David Geffen School of Medicine at the University of California, Los Angeles, USA
    Clin Infect Dis 51:1201-8. 2010
  5. doi request reprint Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin
    Romney M Humphries
    UCLA David Geffen School of Medicine, Department of Pathology and Laboratory Medicine, Los Angeles, CA, USA
    J Med Microbiol 59:1383-6. 2010
  6. pmc Impact of prison status on HIV-related risk behaviors
    Angela L Hudson
    School of Nursing, University of California Los Angeles, CA 90095, USA
    AIDS Behav 15:340-6. 2011
  7. ncbi request reprint Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies
    Debika Bhattacharya
    Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    Clin Gastroenterol Hepatol 4:288-92. 2006
  8. pmc Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in Northern California
    Debika Bhattacharya
    Stanford University, Stanford, California, USA
    J Clin Microbiol 45:1798-803. 2007

Detail Information

Publications8

  1. doi request reprint Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: A novel approach
    Debika Bhattacharya
    Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States UCLA Center for AIDS Research and Education, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States Electronic address
    J Virol Methods 190:34-40. 2013
    ....
  2. pmc Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance
    D Bhattacharya
    Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J STD AIDS 19:780-1. 2008
    ..In HIV/HBV co-infection, measurement of HBV DNA and HBV resistance mutations may identify HBV virological failure before biochemical changes and should be routinely used in the management of HIV/HBV co-infection...
  3. pmc Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis
    Debika Bhattacharya
    University of California, Los Angeles, CA, USA
    J Acquir Immune Defic Syndr 55:170-5. 2010
    ..In HIV/ hepatitis C virus (HCV) coinfection, adverse events (AEs) during HCV therapy account for 12%-39% of treatment discontinuations. It is unknown whether sex influences complications...
  4. pmc Review of hepatitis B therapeutics
    Debika Bhattacharya
    David Geffen School of Medicine at the University of California, Los Angeles, USA
    Clin Infect Dis 51:1201-8. 2010
    ..We will also offer guidelines for the use of available anti-HBV agents and review the emerging challenges in hepatitis B management, including HBV drug resistance, its management, and the potential role of combination therapy...
  5. doi request reprint Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin
    Romney M Humphries
    UCLA David Geffen School of Medicine, Department of Pathology and Laboratory Medicine, Los Angeles, CA, USA
    J Med Microbiol 59:1383-6. 2010
    ..Despite a poor prognosis, the patient recovered, but remains colonized with the pan-resistant isolate...
  6. pmc Impact of prison status on HIV-related risk behaviors
    Angela L Hudson
    School of Nursing, University of California Los Angeles, CA 90095, USA
    AIDS Behav 15:340-6. 2011
    ..As risk for HCV and HIV co-infection continues among homeless ex-offenders, HIV/HCV prevention efforts are needed for this population...
  7. ncbi request reprint Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies
    Debika Bhattacharya
    Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    Clin Gastroenterol Hepatol 4:288-92. 2006
  8. pmc Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in Northern California
    Debika Bhattacharya
    Stanford University, Stanford, California, USA
    J Clin Microbiol 45:1798-803. 2007
    ..Clinicians should assess for nosocomial and community risk factors, realizing that different populations with CO-MRSA SSTI may require separate antimicrobial strategies...